Neos Therapeutics, Inc. (NEOS) |
|---|
| $4.85 52 Week Low | $7.1 2017-04-28 15:02:58 MDT | $11.35 52 Week High |
| Healthcare Sector | Drugs - Generic Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $160,180,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | N/A | Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index. |
ForwardPE: Unknown | 5 Yr Est Growth: 90.00% | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 0.42% | % Above 200 DayMA: 8.40% |
NEOS Performance 52 Weeks: -25.34% | S&P 500 Performance 52 Weeks: 13.50% |
Uptrend is still intact: NEOS is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | NEOS underperforming S&P 500 by -38.84% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -2.47 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 9.62% | 17.28% | Held by fewer than average Insiders. |
| % Held By Institutions | 2.10% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 17.41% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -834.67% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | -216.94% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
| Return on Assets % | -47.13% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $68,283.58 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | 4.03 | 5.52 | Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|